Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient

Jaejun Lee1,2, Hyun Yang1,2, Si Hyun Bae1,2

  • 1Division of Hepatology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Summary

Shear wave elastography (SWE) offers comparable risk stratification for metabolic dysfunction-associated liver disease (MASLD) to vibration-controlled transient elastography (VCTE). Both methods effectively predict liver-related events (LREs) using established algorithms.